ROPIVACAINE
Post-Operative Pain, Non-Human Animal
Tianjin Medical University General HospitalSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 72/ 100
- Competitive Position
- 81/ 100
Competitive context
22 Active assets in the Post-Operative Pain, Non-Human Animal cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lidocaine Instituto Mexicano del Seguro Social | Phase 4 | BBB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Tanta University | Phase 4 | BBB |
NEPENTHE IVO JURISIC | Phase 4 | BBB |
Marcaine The Second Affiliated Hospital of Chongqing Medical University | Phase 4 | BB |
FENTANYL IVO JURISIC | Phase 4 | BB |
View all 38 →
Same molecule, other indications
ROPIVACAINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →